LWM
TEVA icon

Liberty Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Liberty Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed – – 1005
2021
Q3 		$0 Hold
50
– – ﹤0.01% 1235
2021
Q2 		$0 Hold
50
– – ﹤0.01% 1177
2021
Q1 		$0 Hold
50
– – ﹤0.01% 1040
2020
Q4 		$0 Hold
50
– – ﹤0.01% 1069
2020
Q3 		$0 Hold
50
– – ﹤0.01% 953
2020
Q2 		$1K Sell
50
-50
-50% -$565 ﹤0.01% 819
2020
Q1 		$1K Hold
100
– – ﹤0.01% 842
2019
Q4 		$1K Buy
100
+50
+100% +$446 ﹤0.01% 865
2019
Q3 		$0 Hold
50
– – ﹤0.01% 980
2019
Q2 		$0 Sell
50
-189
-79% -$2.28K ﹤0.01% 949
2019
Q1 		$3K Buy
239
+189
+378% +$3.33K ﹤0.01% 605
2018
Q4 		$0 Buy
+50
New +$1.02K ﹤0.01% 794

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Liberty Wealth Management's TEVA Position: Q4 2021 in Review

Liberty Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 50 shares.

Liberty Wealth Management first reported a position in TEVA in Q4 2018 and held it in 12 quarters. The position peaked at $3K in Q1 2019. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Liberty Wealth Management reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 50 Teva Pharmaceuticals shares in Q4 2021.
  • Liberty Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 12 quarters.
  • Liberty Wealth Management's Teva Pharmaceuticals position peaked at $3K in Q1 2019.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.